China SXT Pharmaceuticals (SXTC) Inventory Average (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Inventory Average for 9 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

• Quarterly Inventory Average rose 219.53% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 219.53% YoY) and the FY2026 annual result came in at $1.2 million, up 126.31% from the prior year.
• Inventory Average rose to $1.6 million in Q1 2026 per SXTC's latest filing, from $694378.5 in the prior quarter.
• Over the last five years, Inventory Average for SXTC reached as high as $1.6 million in Q1 2026 and fell as low as $294691.0 in Q1 2023.
• A 5-year average of $661826.7 and a median of $537827.5 in 2022 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average slumped 62.01% — and 2026, when it surged 219.53%.
• Year by year, Inventory Average stood at $537827.5 in 2022, then slumped by 42.42% to $309678.5 in 2023, then soared by 144.8% to $758086.5 in 2024, then slipped by 8.4% to $694378.5 in 2025, then jumped by 135.23% to $1.6 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $1.6 million, $694378.5, and $511184.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.